A detailed history of First Interstate Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, First Interstate Bank holds 8,085 shares of ABBV stock, worth $1.35 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,085
Previous 7,419 8.98%
Holding current value
$1.35 Million
Previous $1.15 Million 28.11%
% of portfolio
0.1%
Previous 0.09%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $106,440 - $121,278
666 Added 8.98%
8,085 $1.47 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $80,633 - $90,812
-586 Reduced 7.32%
7,419 $1.15 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $5,744 - $6,649
-43 Reduced 0.53%
8,005 $1.19 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $139,798 - $173,969
-1,055 Reduced 11.59%
8,048 $1.08 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $182,208 - $209,840
-1,260 Reduced 12.16%
9,103 $1.45 Million
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $39,280 - $47,107
-284 Reduced 2.67%
10,363 $1.68 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $79,183 - $90,818
590 Added 5.87%
10,647 $1.43 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $1.05 Million - $1.33 Million
7,617 Added 312.17%
10,057 $1.54 Million
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $10,558 - $13,100
80 Added 3.39%
2,440 $395,000
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $4,297 - $5,437
-40 Reduced 1.67%
2,360 $320,000
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $12,980 - $14,735
122 Added 5.36%
2,400 $259,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $19,674 - $21,918
-187 Reduced 7.59%
2,278 $256,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $4,829 - $6,520
60 Added 2.49%
2,465 $264,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $125,514 - $147,312
-1,461 Reduced 37.79%
2,405 $211,000
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $9,978 - $13,352
136 Added 3.65%
3,866 $380,000
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $25,800 - $39,116
-400 Reduced 9.69%
3,730 $285,000
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $36,065 - $45,125
500 Added 13.77%
4,130 $365,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $165,007 - $198,386
-2,620 Reduced 41.92%
3,630 $274,000
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $1,905 - $2,435
-29 Reduced 0.46%
6,250 $455,000
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $16,970 - $19,973
-220 Reduced 3.39%
6,279 $506,000
Q4 2018

Jan 31, 2019

SELL
$77.85 - $96.01 $9,731 - $12,001
-125 Reduced 1.89%
6,499 $600,000
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $267,619 - $297,508
-3,010 Reduced 31.24%
6,624 $627,000
Q2 2018

Jul 27, 2018

SELL
$89.78 - $106.23 $27,742 - $32,825
-309 Reduced 3.11%
9,634 $893,000
Q1 2018

Apr 26, 2018

SELL
$92.01 - $123.21 $202,053 - $270,569
-2,196 Reduced 18.09%
9,943 $941,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $161,208 - $176,778
1,800 Added 17.41%
12,139 $1.17 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $722,179 - $922,445
10,339
10,339 $919,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Interstate Bank Portfolio

Follow First Interstate Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Interstate Bank with notifications on news.